CorMedix (CRMD) Intangibles (2019 - 2025)
CorMedix (CRMD) reported Intangibles of $379.1 million for Q4 2025, up 18853.6% on a YoY basis from N/an in Q4 2024, and down 3.76% sequentially from $393.9 million in Q3 2025.
CorMedix (CRMD) Intangibles (2019 - 2025) Analysis & Trends
CorMedix (CRMD) has 4 years of Intangibles data on file, last reported at $379.1 million in Q4 2025.
- For the quarter ending Q4 2025, Intangibles rose 18853.6% year-over-year to $379.1 million; the trailing twelve-month figure through Dec 2025 stood at $379.1 million (up 18853.6% YoY), and the FY2025 full-year result was $379.1 million, up 18853.6% from the prior year.
- Intangibles declined to $379.1 million in Q4 2025, from $393.9 million in the prior quarter.
- In the past five years, Intangibles ranged from a high of $393.9 million in Q3 2025 to a low of $1.7 million in Q2 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 16.97 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 11,640.44 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 61.68 Mn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 2.92 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 418.50 Mn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 1.29 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 266.00 Mn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 55.80 Mn |
| 10 | CorMedix | 546.82 Mn | 391.62 Mn | 107.31 Mn | 379.07 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 379.07 Mn |
| Sep 30, 2025 | 393.90 Mn |
| Jun 30, 2025 | 1.74 Mn |
| Mar 31, 2025 | 1.79 Mn |
| Dec 31, 2024 | 2.00 Mn |
| Sep 30, 2024 | 1.90 Mn |
| Sep 30, 2020 | 372,454.00 |
| Jun 30, 2020 | 296,574.00 |
| Dec 31, 2019 | 10,081.00 |